The Leishmania donovani Ortholog of the Glycosylphosphatidylinositol Anchor Biosynthesis Cofactor PBN1 Is Essential for Host Infection

The Leishmania donovani Ortholog of the Glycosylphosphatidylinositol Anchor Biosynthesis Cofactor PBN1 Is Essential for Host Infection

ABSTRACT Visceral leishmaniasis is a deadly infectious disease caused by Leishmania donovani, a kinetoplastid parasite for which no licensed vaccine is available. To identify potential vaccine candidates, we systematically identified genes encoding putative cell surface and secreted proteins essenti...

Full description

Bibliographic Details
Main Authors:	Adam Roberts, Rupa Nagar, Cordelia Brandt, Katherine Harcourt, Simon Clare, Michael A. J. Ferguson, Gavin J. Wright
Format:	Article
Language:	English
Published:	American Society for Microbiology 2022-06-01
Series:	mBio
Subjects:	glycophosphatidylinositol biosynthesis parasitology mass spectrometry leishmaniasis enzyme bioluminescence
Online Access:	https://journals.asm.org/doi/10.1128/mbio.00433-22

Similar Items

Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasis
by: Sarfaraz Ahmad Ejazi, et al.
Published: (2020-05-01)

Cutaneous Leishmania mexicana infections in the United States: defining strains through endemic human pediatric cases in northern Texas
by: Binita Nepal, et al.
Published: (2024-03-01)

CRYOPRESERVATION OF LEISHMANIA DONOVANI PROMASTIGOTES AT -80°C
by: E. Kaneva
Published: (2022-12-01)

Molecular characteristic of treatment failure clinical isolates of Leishmania major
by: Gilda Eslami, et al.
Published: (2021-03-01)

PIGO‐CDG: A case study with a new genotype, expansion of the phenotype, literature review, and nosological considerations
by: Rodrigo Tzovenos Starosta, et al.
Published: (2023-11-01)

Leishmania donovani Nucleoside Hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection
by: Dirlei eNico, et al.
Published: (2014-06-01)

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
by: H. V. Yamuna D. Siriwardana, et al.
Published: (2007-03-01)

Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+-epitopes of Leishmania donovani Nucleoside Hydrolase terminal domains
by: Dirlei eNico, et al.
Published: (2014-05-01)

Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
by: Gilles Darcis, et al.
Published: (2017-07-01)

Red cell antigens: Structure and function
by: Pourazar Abbasali
Published: (2007-01-01)

Unusual malar rash with ulceration: What can we expect?
by: Kouki Chaima, et al.
Published: (2023-04-01)

The first documentation of the immune response to cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka.
by: D. Atapattu, et al.
Published: (2017-10-01)

An investigation about the possible role of cattle and goats as reservoir hosts for Leishmania donovani in Bangladesh
by: Mohmmad Zahangir Alam, et al.
Published: (2018-01-01)

Deletion of Glutamine Synthetase Gene Disrupts the Survivability and Infectivity of Leishmania donovani
by: Vinay Kumar, et al.
Published: (2021-02-01)

Global genome diversity of the Leishmania donovani complex
by: Susanne U Franssen, et al.
Published: (2020-03-01)

Experimental chemotherapy with Allium sativum (Liliaceae) methanolic extract in rodents infected with Leishmania major and Leishmania donovani
by: Byrum W. Wabwoba, Christopher O. Anjili, Moses M. Ngeiywa, Peter K. Ngure, Elizabeth M. Kigondu, Johnstone Ingonga & Judith Makwali
Published: (2010-09-01)

Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease
by: Neelima B. Chauhan
Published: (2003-11-01)

Tissue Specific Dual RNA-Seq Defines Host–Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum
by: Sarah Forrester, et al.
Published: (2022-04-01)

Leishmania donovani populations in Eastern Sudan: temporal structuring and a link between human and canine transmission
by: Rania Baleela, et al.
Published: (2014-11-01)

First report of cutaneous leishmaniasis caused by Leishmania donovani in Ethiopia
by: Gashaw Azanaw Amare, et al.
Published: (2023-12-01)

Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival
by: Kendi Okuda, et al.
Published: (2022-09-01)

Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
by: Lieselotte Van Bockstal, et al.
Published: (2020-08-01)

F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis
by: Eugenia Carrillo, et al.
Published: (2017-07-01)

Source Tracing of Leishmania donovani in Emerging Foci of Visceral Leishmaniasis, Western Nepal
by: Pieter Monsieurs, et al.
Published: (2024-03-01)

In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani
by: Subhadip Saha, et al.
Published: (2022-08-01)

The role of the Leishmania mexicana amastigote flagellum in parasite-host interactions
by: Valli, J
Published: (2017)

Central Asian Rodents as Model Animals for <i>Leishmania</i> <i>major</i> and <i>Leishmania donovani</i> Research
by: Barbora Vojtkova, et al.
Published: (2020-09-01)

Leishmania mexicana promotes pain-reducing metabolomic reprogramming in cutaneous lesions
by: Greta Volpedo, et al.
Published: (2023-12-01)

Endosymbiotic RNA virus inhibits Leishmania-induced caspase-11 activation
by: Renan V.H. de Carvalho, et al.
Published: (2021-01-01)

Challenges and Tools for In Vitro <i>Leishmania</i> Exploratory Screening in the Drug Development Process: An Updated Review
by: Anita Cohen, et al.
Published: (2021-12-01)

Association of hepatic lipase with proteoglycans stimulates the production of proteoglycans in vivo and in vitro
by: Sung-Joon Lee, et al.
Published: (2004-07-01)

Leishmania donovani Infection with Atypical Cutaneous Manifestations, Himachal Pradesh, India, 2014–2018
by: Lovlesh Thakur, et al.
Published: (2020-08-01)

Immunogenicity and protective efficacy of tuzin protein as a vaccine candidate in Leishmania donovani-infected BALB/c mice
by: Moodu Devender, et al.
Published: (2024-01-01)

Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients
by: Md Anik Ashfaq Khan, et al.
Published: (2021-09-01)

Polymerase chain reaction detection of LeishmaniaDNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is Leishmania donovani
by: Shalindra Ranasinghe, et al.
Published: (2015-12-01)

Development of Quantitative Rapid Isothermal Amplification Assay for <i>Leishmania donovani</i>
by: Md Anik Ashfaq Khan, et al.
Published: (2021-10-01)

Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain
by: Sumudu R. Samarasinghe, et al.
Published: (2018-11-01)

Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis
by: Vijani N. Somaratne, et al.
Published: (2019-01-01)

An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran
by: Mahin Farahmand, et al.